In-depth research guides covering peptides, compounds, and laboratory supplies. For research use only.
What Are Orexins (Hypocretins)? Orexins — also known as hypocretins — are a pair of excitatory neuropeptides produced by a relatively small cluster of neurons in the lateral hypothalamus.
This material is for informational and research purposes only. It is not intended as medical advice and does not constitute a recommendation for human use. Always consult qualified professionals before making any decisions related to peptide research.
Melanotan I and Melanotan II both stimulate melanin production but differ significantly in receptor selectivity. Melanotan I is selective for MC1R. Melanotan II also activates MC4R, producing sexual function and appetite effects alongside tanning.
Vertigo is caused by vestibular system dysfunction — in the inner ear or brain’s balance processing centers. BPC-157, Semax, and Cerebrolysin have neuroprotective and vascular properties relevant to vestibular research.
Tinnitus affects 15% of adults and has no universally effective treatment. Research into BPC-157 and Semax explores neuroprotective and vascular mechanisms that may be relevant to cochlear health and auditory pathway research.
BPC-157, TB-500, GHK-Cu, IGF-1 LR3 — peptide names follow several naming conventions. This guide explains the logic behind peptide nomenclature so researchers can decode names and read the literature more accurately.
What Is GHRP-2? GHRP-2 (pralmorelin) is a synthetic hexapeptide growth hormone secretagogue with the amino acid sequence D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH 2 .
What Is SLU-PP-332? SLU-PP-332 is a synthetic small molecule compound developed at Washington University in St. Louis — the “SLU” prefix in its name reflects this institutional origin.
Semaglutide is the established GLP-1 agonist behind Ozempic. Survodutide targets both GLP-1 and glucagon receptors, with Phase 2 data showing potentially greater fat loss. A research comparison of both compounds.
Cluster headaches are among the most painful conditions known. Early research explores how peptides like BPC-157 and Selank may influence the neurological and inflammatory pathways involved in these severe headache attacks.
